Testosterone(睾酮)
Monoisotopic: 288.20893014
Testosterone is a steroid sex hormone found in both men and women. In men, testosterone is produced primarily by the Leydig (interstitial) cells of the testes when stimulated by luteinizing hormone (LH). It functions to stimulate spermatogenesis, promote physical and functional maturation of spermatozoa, maintain accessory organs of the male reproductive tract, support development of secondary sexual characteristics, stimulate growth and metabolism throughout the body and influence brain development by stimulating sexual behaviors and sexual drive. In women, testosterone is produced by the ovaries (25%), adrenals (25%) and via peripheral conversion from androstenedione (50%). Testerone in women functions to maintain libido and general wellbeing. Testosterone exerts a negative feedback mechanism on pituitary release of LH and follicle-stimulating hormone (FSH). Testosterone may be further converted to dihydrotestosterone or estradiol depending on the tissue.
- Alza corp
- Auxilium pharmaceuticals
- Bedford laboratories div ben venue laboratories inc
- Columbia laboratories inc
- Eli lilly and co
- Endo pharmaceutical solutions inc
- Heather drug co inc
- Impax laboratories inc
- Inwood laboratories inc sub forest laboratories inc
- Kv pharmaceutical co
- Lannett co inc
- Novartis pharmaceuticals corp
- Paddock laboratories inc
- Par pharmaceutical
- Parke davis div warner lambert co
- Pharmacia and upjohn co
- Private formulations inc
- Purepac pharmaceutical co
- Sandoz canada inc
- Schering corp sub schering plough corp
- Slate pharmaceuticals inc
- Solvay Pharmaceuticals, Inc.
- Synerx pharma llc
- Tablicaps inc
- Unimed pharmaceuticals inc
- Usl pharma inc
- Valeant pharmaceuticals international
- Watson laboratories
- Watson laboratories inc
- West ward pharmaceutical corp
- Abraxis BioScience Inc.
- Amneal Pharmaceuticals
- Andapharm
- Anip Acquisition Co.
- A-S Medication Solutions LLC
- Auxilium Pharmaceuticals
- Bartor Pharmaceutical
- Breckenridge Pharmaceuticals
- C.O. Truxton Inc.
- Carlisle Laboratories Inc.
- Columbia Labs
- Contract Pharm
- Creekwood Pharmaceutical Inc.
- Cutis Pharma Inc.
- Darby Dental Supply Co. Inc.
- Dispensing Solutions
- DPT Laboratories Ltd.
- Endo Pharmaceuticals Inc.
- Glenmark Generics Ltd.
- Global Pharmaceuticals
- Indevus Pharmaceuticals
- Laboratoires Besins International
- Lannett Co. Inc.
- Lunsco Inc.
- Marlex Pharmaceuticals
- Martica Enterprises Inc.
- Martin Surgical Supply
- Medisca Inc.
- Merit Pharmaceuticals
- Microtest Laboratories Inc.
- Murfreesboro Pharmaceutical Nursing Supply
- National Pharmaceuticals
- Paddock Labs
- Pharmaceutics International Inc.
- Pharmacia Inc.
- Pharmaforce Inc.
- Pharmascience Inc.
- Physicians Total Care Inc.
- Prasco Labs
- Primedics Laboratories
- Rebel Distributors Corp.
- Resource Optimization and Innovation LLC
- Sandoz
- Schering-Plough Inc.
- Schwarz Pharma Inc.
- Slate Pharmaceuticals Inc.
- Solvay Pharmaceuticals
- Southwood Pharmaceuticals
- Star Pharmaceuticals Inc.
- Stat Rx Usa
- Syntho Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd.
- UNIMED
- Unimed Pharmaceuticals Inc.
- Valeant Ltd.
- Watson Pharmaceuticals
Synthesis Reference | Not Available |
General Reference |
|
Type | small molecule |
Classes |
|
Substructures |
|
Indication | To be used as hormone replacement or substitution of diminished or absent endogenous testosterone. Use in males: For management of congenital or acquired hypogonadism, hypogonadism associated with HIV infection, and male climacteric (andopause). Use in females: For palliative treatment of androgen-responsive, advanced, inoperable, metastatis (skeletal) carcinoma of the breast in women who are 1-5 years postmenopausal; testosterone esters may be used in combination with estrogens in the management of moderate to severe vasomotor symptoms associated with menopause in women who do not respond to adequately to estrogen therapy alone. | ||||||||||||||||||||||||||||||||||||
Pharmacodynamics | Testosterone is a steroid hormone from the androgen group. Testosterone is primarily secreted from the testes of males. In females, it is produced in the ovaries, adrenal glands and by conversion of adrostenedione in the periphery. It is the principal male sex hormone and an anabolic steroid. In both males and females, it plays key roles in health and well-being. Examples include enhanced libido, energy, immune function, and protection against osteoporosis. On average, the adult male body produces about twenty times the amount of testosterone than an adult female's body does. | ||||||||||||||||||||||||||||||||||||
Mechanism of action | The effects of testosterone in humans and other vertebrates occur by way of two main mechanisms: by activation of the androgen receptor (directly or as DHT), and by conversion to estradiol and activation of certain estrogen receptors. Free testosterone (T) is transported into the cytoplasm of target tissue cells, where it can bind to the androgen receptor, or can be reduced to 5α-dihydrotestosterone (DHT) by the cytoplasmic enzyme 5α-reductase. DHT binds to the same androgen receptor even more strongly than T, so that its androgenic potency is about 2.5 times that of T. The T-receptor or DHT-receptor complex undergoes a structural change that allows it to move into the cell nucleus and bind directly to specific nucleotide sequences of the chromosomal DNA. The areas of binding are called hormone response elements (HREs), and influence transcriptional activity of certain genes, producing the androgen effects. | ||||||||||||||||||||||||||||||||||||
Absorption | Approximately 10% of the testosterone dose applied on the skin surface is absorbed into systemic circulation | ||||||||||||||||||||||||||||||||||||
Volume of distribution | Not Available | ||||||||||||||||||||||||||||||||||||
Protein binding | 40% of testosterone in plasma is bound to sex hormone-binding globulin and 2% remains unbound and the rest is bound to albumin and other proteins. | ||||||||||||||||||||||||||||||||||||
Metabolism |
Testosterone is metabolized to 17-keto steroids through two different pathways. The major active metabolites are estradiol and dihydrotestosterone (DHT).
Important The metabolism module of DrugBank is currently in beta. Questions or suggestions? Please contact us.
|
||||||||||||||||||||||||||||||||||||
Route of elimination | About 90% of a dose of testosterone given intramuscularly is excreted in the urine as glucuronic and sulfuric acid conjugates of testosterone and its metabolites; about 6% of a dose is excreted in the feces, mostly in the unconjugated form. | ||||||||||||||||||||||||||||||||||||
Half life | 10-100 minutes | ||||||||||||||||||||||||||||||||||||
Clearance | Not Available | ||||||||||||||||||||||||||||||||||||
Toxicity | Side effects include amnesia, anxiety, discolored hair, dizziness, dry skin, hirsutism, hostility, impaired urination, paresthesia, penis disorder, peripheral edema, sweating, and vasodilation. | ||||||||||||||||||||||||||||||||||||
Affected organisms |
|
||||||||||||||||||||||||||||||||||||
Pathways | Not Available |
Properties | |||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
State | solid | ||||||||||||||||||||||||||||||||||||||||||
Experimental Properties |
|
||||||||||||||||||||||||||||||||||||||||||
Predicted Properties |
|
Drug | Interaction |
---|---|
Acenocoumarol | The androgen, Testosterone, may incrase the anticoagulant effect of the Vitamin K antagonist, Acenocoumarol. Monitor for changes in the therapeutic effect of Acenocoumarol if Testosterone is initiated, discontinued or dose changed. |
Anisindione | The androgen may increase the anticoagulant effect of anisindione. |
Cyclosporine | The androgen, Testosterone, may increase the hepatotoxicity of Cyclosporine. Testosterone may also elevate serum concentrations of Cyclosporine. Consider alternate therapy or monitor for signs of renal and hepatic toxicity. |
Dicumarol | The androgen may increase the anticoagulant effect of dicumarol. |
Docetaxel | Testosterone may increase the serum levels and toxicity of docetaxel. |
Warfarin | Testosterone may increase the serum concentration and anticoagulant effect of warfarin. Monitor for changes in prothrombin time and therapeutic effects of warfarin if testosterone is initiated, discontinued or dose changed. |